Related Experiment Video
Updated: Jul 11, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
CT-based Fat Distribution-Informed Reinterpretation of BMI for Disease-Weighted Nutritional Risk Classification in
Hualong Zheng1, Lingkang Zhang1, Weifeng Chen1
1Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China (H.Z., L.Z., W.C., C.L., Z.L., C.H., J.X., J.W.); Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China (H.Z., L.Z., W.C., C.L., Z.L., C.H., J.X., J.W.).
A new Nutritional Risk Score Scale (NRSS) combined with tumor stage improves prognosis prediction for locally advanced gastric cancer (LAGC) patients after neoadjuvant chemotherapy (NACT). This integrated approach offers better risk stratification than current staging systems.
Area of Science:
- Oncology
- Gastroenterology
- Metabolic Medicine
Background:
- Prognosis in locally advanced gastric cancer (LAGC) is influenced by nutritional status, but current staging lacks assessment of treatment-related changes.
- Neoadjuvant chemotherapy (NACT) can alter nutritional and metabolic status, impacting patient outcomes.
- Existing staging systems do not fully capture prognostic information related to nutritional status during NACT.
Purpose of the Study:
- To develop and validate a novel prognostic classification integrating nutritional-metabolic status with tumor burden for LAGC patients.
- To assess the performance of this new classification against the current AJCC staging system.
Main Methods:
- Retrospective analysis of 643 LAGC patients undergoing NACT and curative gastrectomy.
- Development of a sex-specific Nutritional Risk Score Scale (NRSS) using baseline BMI and changes in visceral-to-subcutaneous adipose ratio (ΔVSR).
- Creation of an integrated NRSS-ypN classification (Grades I-IV) and comparison with AJCC 8th ypTNM staging.
Main Results:
- Higher NRSS stages correlated with significantly worse overall survival (OS) and disease-free survival (DFS).
- Both NRSS and ypN stage were identified as independent prognostic factors.
- The NRSS-ypN classification showed superior prognostic discrimination compared to AJCC 8th ypTNM staging (C-index for OS: 0.715 vs. 0.693).
- 3-year OS rates varied significantly across NRSS-ypN Grades I-IV (87.9% to 29.5%).
Conclusions:
- The NRSS-ypN classification effectively integrates nutritional-metabolic status and tumor burden.
- This novel classification improves postoperative risk stratification for LAGC patients receiving neoadjuvant therapy.
- The findings suggest a potential refinement of staging systems for gastric cancer treatment planning.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

